Skip to main content
. Author manuscript; available in PMC: 2012 Jan 28.
Published in final edited form as: AIDS. 2011 Jan 28;25(3):357–365. doi: 10.1097/QAD.0b013e32834171f8

Table 3.

Distribution of the CNS penetration effectiveness (CPE) score by number of ARVs in the regimen, total visits=10,413

Number of ARVs in Regimen
CPE Score Overall N=10,413 ARVs ≤3 N=7367 ARVs >3 N=3046
0 – 0.5 323 (3%) 319 (4%) 4 (<1%)
1 1,862 (18%) 1,629 (22%) 233 (8%)
1.5 2,048 (20%) 1,787 (24%) 261 (9%)
2 3,412 (33%) 2,753 (37%) 659 (22%)
2.5 1,458 (14%) 864 (12%) 594 (20%)
3 1,052 (10%) 15 (0%) 1,037 (34%)
3.5 241 (2%) 0 (0%) 241 (8%)
4 – 4.5 17 (<1%) 0 (0%) 17 (1%)
Median 2 1.5 2.5
Q1, Q3 1.5, 2.5 1, 2 2, 3